top of page
Vicore_1_0.5x.png
Logo_fina_whitel_Rityta 1 kopia.png
VICORE - ATRAGs mechanism of action
Vicore Pharma Logo colour 1.0.jpg

overview

Hyperfine Studios partnered with Vicore to create a mechanism of action for their drug candidate ATRAG.  The drug promotes alveolar repair and maintenance of alveolar integrity in idiopathic pulmonary fibrosis (IPF). IPF is a condition in which the lungs become scarred, and breathing becomes increasingly difficult. There’s no cure for IPF at the moment. 

challenge

The primary goal of the animation was to explain the mechanism of action for ATRAGs in an easy-to-understand and visually appealing way. The client also wished the animation to differentiated them from the competitors.   

Vicore_1b_0.5x.png

Animation

Vicore_1_0.5x.png
Vicore_4_0.5x.png
Vicore_5_0.5x.png

Phone

+46 (0) 702 887 342

Email

Social Media

  • LinkedIn
  • Instagram
  • Facebook
bottom of page